Stock screener

ACAD

Conviction 86HealthcareScan · Mon, Aug 10, 2026
ACAD$29.40+0.65%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.89M
May 11May 28Jun 16Jul 6Jul 23Aug 10
ACADIA PHARMACEUTICALS INCPHARMACEUTICAL PREPARATIONSwww.acadia.com ↗
Price29.40
Change+0.65%
Gap-0.46%
Rel volume1.71×
Avg volume1.76M
Avg $ vol47.25M
SMA 2026.33
SMA 5024.46
SMA 20023.85
Price vs 50+20.21%
Price vs 200+23.28%
MA stackbullish
50/200 crossgolden · 6d
Supertrendup · 26.37
RSI (14)74
MACD hist0.31
MACD crossbull · 3d
Stoch %K / %D96 / 90
ADX (14)45
+DI / −DI37 / 9
RSI divergenceBearish
MACD divergenceBearish
ATR %+3.23%
ADR %3.22%
52w high29.40
52w low20.06
From 52w high+0.00%
Above 52w low+46.56%
New 52w highYes
SqueezeOff
Bollinger width21.84%
%B1.03
Donchian pos95.92%
Donchian high29.62
Donchian low24.23
AVWAP (52w high)29.35
vs AVWAP high+0.17%
AVWAP (52w low)23.68
vs AVWAP low+24.17%
OBV trendUp
Chaikin MF (20)0.16
Today vs 20d1.71×
Avg vol (14d)1.89M
Avg vol (20d)1.76M
Avg $ vol (20d)47.25M
Market cap5.07B
RS 3m (vs SPY)+23.78%
RS 6m (vs SPY)+10.40%
RS line new highYes
Trend template6/8
Technical rank88.0
1 week+14.80%
1 month+12.13%
3 months+31.25%
6 months+24.79%
1 year+20.49%
YTD+11.83%
P/E12.96
P/B3.88
P/S4.73
P/FCF48.18
EPS2.30
Div yield—
ROE29.92%
ROA22.43%
Debt/Eq0.00
Current3.39
EV/EBITDA44.57
Gross margin63.91%
Net margin36.49%
Rev growth11.87%
EPS growth72.66%
Price target34.07
Target upside15.88%
Analyst ratingBuy
Institutional106.24%
Ent. value4.68B
Revenue307.96M
Net income31.5M
Gross profit—
Free cash flow105.15M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out171.24M
Employees798
ListedThu, May 27, 2004
Free float126.37M
Float %74.1%
Short interest11.03M
Days to cover7.6d
Short volume31.4%
Squeeze score53 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.18 vs $0.06
Last surprise+200.0% beat
Setup gradeA+
Conviction86 / 100
Pattern quality—
Tech rank88.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance26.95
Support22.54
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACAD

All disclosures →
No recent disclosed trades by Congress in ACAD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACAD · 4 buys · 6 sells

InsiderSideShares
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Common Stock · 2026-08-06
Sell9.29K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-08-06
Exercise14.29K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Common Stock · 2026-08-06
Exercise14.29K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Common Stock · 2026-08-06
Sell5K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Common Stock · 2026-08-05
Exercise5.85K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-08-05
Exercise5.85K
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER · Common Stock · 2026-08-05
Sell5.85K
Kihara James
PRINCIPAL ACCOUNTING OFFICER · Common Stock · 2026-06-26
Sell11.42K
Baker Bros. Advisors (GP) LLC
Director · Common Stock · 2026-05-29
Grant18.62K
BAKER FELIX
Director · Common Stock · 2026-05-29
Grant18.62K

SEC filings

EDGAR filings in ACAD · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.